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Abstract
Background: Silibinin, a biologically active compound of milk thistle, has chemopreventive effects on cancer cell
lines. Recently it was reported that silibinin inhibited tumor growth through activation of the apoptotic signaling
pathway. Although various evidences showed multiple signaling pathways of silibinin in apoptosis, there were no
reports to address the clear mechanism of ROS-mediated pathway in prostate cancer PC-3 cells. Several studies
suggested that reactive oxygen species (ROS) play an important role in various signaling cascades, but the primary
source of ROS was currently unclear.
Methods: The effect of silibinin was investigated on cell growth of prostate cell lines by MTT assay. We examined
whether silibinin induced apoptosis through production of ROS using flow cytometry. Expression of apoptosis-,
endoplasmic reticulum (ER)-related protein and gene were determined by western blotting and RT-PCR, respectively.
Results: Results showed that silibinin triggered mitochondrial ROS production through NOX4 expression and finally led to
induce apoptosis. In addition, mitochondrial ROS caused ER stress through disruption of Ca2+ homeostasis. Co-treatment of
ROS inhibitor reduced the silibinin-induced apoptosis through the inhibition of NOX4 expression, resulting in reduction of
both Ca2+ level and ER stress response.
Conclusions: Taken together, silibinin induced mitochondrial ROS-dependent apoptosis through NOX4, which is
associated with disruption of Ca2+ homeostasis and ER stress response. Therefore, the regulation of NOX4, mitochondrial
ROS producer, could be a potential target for the treatment of prostate cancer.
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Background
Reactive oxygen species (ROS) can act as secondary
messengers in cancer cell signaling. It plays an important
role in various cellular response, including cell growth,
differentiation, survival, death, inflammation and im-
mune response [1, 2]. The sources of ROS are various
organelles and enzymes system including mitochondria,
endoplasmic reticulum, peroxisomes and NADPH
oxidase (NOX) [3]. ROS are generated in forms of
superoxide anion (O2–•), hydroxyl radical (OH•) and
hydrogen peroxide (H2O2) in living organisms [4]. Most
of O2–• are produced by NOXs, xanthine oxidase and
the mitochondrial electron-transport chain [5]. Extracel-
lular stresses including toxin, growth factors, ROS, ultra-
violet radiation, viral infection and anti-cancer agents
are known to trigger apoptosis in many studies [6–9]. In
addition, apoptosis occurs from the changes of mito-
chondrial membrane potential (MMP, ΔΨm) and release
of pro-apoptotic factor such as cytochrome c [10]. ROS
are critically important signals to activate endoplasmic
reticulum (ER) stress as well as apoptosis by a variety of
stimulating conditions [11].
Recently, several studies have reported that the apop-
tosis is related with ER stress responses in cancer cell
lines [11, 12]. ER stress is involved in the initiation of
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apoptosis by at least two different mechanisms, namely
the unfolded protein response (UPR) and Ca2+ signaling
[13, 14]. The UPR-mediated signals consist of a complex
interaction between three signaling, inositol requiring
enzyme 1 (IRE1)-X box-bonding protein 1 (XBP1) sig-
naling, pancreatic ER kinase (PKR)-like ER kinase
(PERK)-eukaryotic initiation factor 2α (eIF2α) signaling
and activating transcription factor 6 (ATF6) signaling
[15]. The activation of ER membrane-resident caspase-
4/12 (human/mice) and induction of CHOP stimulate
ER stress-mediated apoptosis [16, 17]. Subsequently, the
typical signaling of apoptosis mainly lead to the activa-
tion of intracellular caspases, major activator of the
mitochondrial-dependent pathway [18]. ER is the main
intracellular storage compartment for Ca2+, which is an
important secondary messenger required for cellular
functions. Changes of cellular Ca2+ homeostasis includ-
ing cytosolic Ca2+ overload, ER Ca2+ depletion and mito-
chondrial Ca2+ increase induce apoptosis [19, 20]. The
ER-mitochondria interaction supports communication
between the two organelles, including the exchange of
Ca2+, which controls ER chaperone protein, mitochon-
drial ATP production and apoptosis [21].
Silibinin, a major biologically active constituent of sily-
marin from milk thistle extract, has been used clinically
for its hepatoprotective action for more than three de-
cades in Europe and recently in Asia and the United
States [22]. It has been reported that it induces apoptosis
by regulating the cell cycle arrest in human bladder car-
cinoma cells and human colon carcinoma HT-29 cell
[23, 24]. Other reports in murine orthotopic hepatocar-
cinoma model have indicated that it inhibits tumor
growth through the activation of TRAIL/death receptor/
apoptotic signaling pathway, both in vitro and in vivo
[25]. In addition, it has been shown anti-tumor effect in
which induces apoptosis through a p53-dependent path-
way involving Bcl-2/Bax, cytochrome c release and cas-
pase activation [26]. So far, it has not been clarified that
production of ROS or Ca2+ signaling-mediated ER stress
play a critical role in the silibinin-induced apoptosis in
human prostate cancer PC-3 cells. Therefore, we investi-
gated whether production of ROS by silibinin causes ER
stress through changes of Ca2+ concentration and
whether these intracellular signaling pathways lead to
cellular apoptosis.
Methods
Reagents and antibodies
3-(4,5-Dimethyl-thiazol-2-yl)-2,5-diphenyltertrazolium brom-
ide (MTT), propidium iodide (PI), 6-diamidino-2-phenylindo
le dihydrochloride (DAPI), 2′,7′-dichlorfluorescein-diacetate
(DCFH-DA) and 4-(6-Acetoxymethoxy-2,7-dichloro-3-oxo-
9-xanthenyl)-4′-methyl-2,2′(ethylenedioxy)dianiline-N,N,N′,
N′-tetraacetic acid tetrakis (acetoxymethyl) ester (Fluo-3/
AM) were purchased from Sigma Chemical Co. (St. Louis,
MO, USA). 1,2-bis-(o-Aminophenoxy) ethane-tetraacetic
acid tetra-(acetoxymethyl) ester (BAPTA/AM), Diphenyle-
neiodonium (DPI), Z-DEVD-FMK and Z-YVAD-FMK were
purchased from Calbiochem (Merck, Darmstadt, Germany)
and R&D Systems (Minneapolis, MN, USA), respectively.
FITC Annexin-V apoptosis Detection kit and Caspase-3 Col-
orimetric Assay Kit were purchased from BD Bioscience (San
Jose, CA, USA) and Assay Design Inc. (Ann Arbor, Michigan,
USA), respectively. RiboEx_column™ kit was purchased from
GeneAll Biotechnology Co. (Seoul, Korea). TOPscript™ RT
DryMIX kit (Enzynomics, Deajeon, Korea) and Emeral-
dAmp PCR masterMIX (TAKARA, Otsu, Japan) were
obtained. The ECL Western Kit was purchased from iN-
tRON Biotechnology (Seongnam, Korea). Antibodies for
NOX4, Caspase-3 and β-Actin were purchased from Santa
Cruz Biotechnology (Dallas, TX, USA). Antibodies for
poly (ADP-ribose) polymerase-1 (PARP-1), Bip, IRE1α,
and CHOP were purchased from Cell Signaling (Beverly,
MA, USA). MitoSOX was purchased from Invitrogen
(Grand Island, NY, USA).
Cell lines and cell culture
Human prostate cell lines, PC-3, LNCaP and RWPE-1
cells were obtained from the American Type Culture
Collection (ATCC, Manassas, VA, USA). Prostate can-
cer PC-3 and LNCaP cells were cultured in Dulbecco’s
modified Eagle’s minimal medium (DMEM, WelGENE
Inc., Korea) and Roswell Park Memorial Institute
(RPMI) 1640 (WelGENE Inc., Korea) supplemented
with 10 % FBS and 1 % penicillin-streptomycin solution
with 5 % CO2 at 37 °C, respectively. Prostate normal
RWPE-1 cells were cultured in keratinocyte serum-free
media (K-SFM) containing 2.5 μg of epidermal growth
factor (EGF), 25 mg of bovine pituitary extract (BPE,
GIBCO) and 1 % penicillin-streptomycin solution with
5 % CO2 at 37 °C.
Cell viability assay
Cell viability was determined using the 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay. The prostate cancer PC-3 cells were seeded at a
density of 1 × 104/ml in a 48-well culture dish and
treated with silibinin of various concentrations for 24
and 48 h. After incubation, these cells were treated with
0.5 mg/ml of the MTT solution for further 3 h incuba-
tion and the precipitates were dissolved in dimethyl
sulfoxide to dissolve the MTT-formazan complex. Ab-
sorbance was recorded on a microplate reader (Molecu-
lar Devices, Sunnyvale, CA, USA) at a wavelength of
540 nm. The cell viability was determined the relatives
as their percentage of the treated cells to one of the un-
treated cells by comparing their optical densities.
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Apoptosis assay
Apoptotic cells were quantified and analyzed using an
annexin V-FITC detection kit and flow cytometry. Briefly,
the PC-3 cells were treated with 150 μM of silibinin for
48 h. Then the cells were washed with phosphate buffered
saline (PBS) and were collected. Harvested cells were
mixed in 1X binding buffer and incubated with an annexin
V/PI double staining solution at room temperature for
15 min. Then, the staining cells were analyzed by flow cy-
tometry (FACS Calibur, Becton Dickinson, San Jose, CA,
USA) and the CellQuest software (Becton Dickinson Co.).
Measurement of MMP, Ca2+ flux and ROS concentration
MMP, Ca2+ and ROS levels were determined by the
DiOC6, Fluo-3/AM and DCFH-DA, respectively. Briefly,
silibinin-treated PC-3 cells in the presence or absence of
each inhibitor were trypsinized, washed and incubated
with each dye, a fluorescent marker, at 37 °C for 30 min.
Fluorescence positive cells were measured by flow
cytometry with CellQuest analysis software.
Immunofluorescence confocal microscopy
The mitochondrial ROS production was measured by con-
focal microscopy after staining with MitoSOX (Invitrogen,
Waltham, MA, USA). Briefly, PC-3 cells were seeded on
coverglass bottom dish and treated with 150 μM of silibinin
for 24 h. Then the cells were incubated with 5 μM
MitoSOX and fixed with 4 % paraformaldehyde for 10 min
at room temperature. After fixation, the cells were washed
twice with PBS and then incubated with 1 μg/ml DAPI so-
lution at 4 °C for 15 min. Images were acquired using a
confocal microscope (Olympus, Tokyo, Japan). For NOX4
localization assay, PC-3 cells were stained with 5 μM Mito-
SOX and fixed. Cells were subsequently permeabilized with
0.1 % triton X-100 for 10 min and blocked with 5 % BSA,
and incubated with NOX4 primary antibody. Cells were
washed with PBS and incubated in FITC-conjugated sec-
ondary antibody for 1 h at room temperature and then
stained with DAPI solution. Stained cells were visualized by
an Olympus confocal microscope.
RNA extraction and reverse transcription PCR
Total RNA was isolated using RiboEx_column™ kit ac-
cording to the manufacturer’s instructions. Reverse tran-
scription (RT) was carried out with 2 μg RNA and Oligo
dT using TOPscript™ RT DryMIX kit, and the resulting
cDNA was subjected to PCR. The sequence of the primers
used in the PCR was the following: NOX1 (F: 5′ GTA
CAA ATT CCA GTG TGC AGA CCA C 3′; R: 5′ CAG
ACT GGA ATA TCG GTG ACA GCA 3′), NOX2 (F: 5′
GCT GTT CAA TGC TTG TGG CT 3′; R: 5′ TCT CCT
CAT CAT GGT GCA CA 3′), NOX3 (F: 5′ GGA TCG
GAG TCA CTC CCT TCG CTG 3′; R: 5′ ATG AAC
ACC TCT GGG GTC AGC TGA 3′), NOX4 (F: 5′ CTC
AGC GGA ATC AAT CAG CTG TG 3′; R: 5′ AGA
GGA ACA CGA CAA TCA GCC TTA G 3′), NOX5 (F:
5′ TTA TGG GCT ACG TGG TAG TGG G 3′; R: 5′
GAA CCG TGT ACC CAG CCA AT 3′), XBP1 (F: 5′
CCT TGT AGT TGA GAA CCA GG 3′; R: 5′ GGG
GCT TGG TAT ATA TGT GG 3′), Bip (F: 5′ TGC AGC
AGG ACA TCA AGT 3′; R: 5′ CGC TGG TCA AAG
TCT TCT CC 3′), CHOP (F 5′ GCG TCT AGA ATG
GCA GCT GAG TCA TTG CC 3′; R: 5′ GCG TCT AGA
TCA TGC TTG GTG GAG ATT C 3′), and GAPDH (F:
5′ CCA CCC ATG GCA AAT TCC ATG GCA 3′; R: 5′
GCG TCT AGA TCA TGC TTG GTG GAG ATT C 3′).
The amplification was performed with EmeraldAmp PCR
master MIX in Mycycler Thermal Cycler (Bio-Rad
Laboratories Inc., Hercules, CA).
Western blotting
Cell extracts were prepared by incubating the cells in lysis
buffer [150 mM NaCl, 10 mM Tris (pH 7.4), 5 mM EDTA
(pH 8.0), 1 % Triton X-100, 1 mM PMSF, 20 mg/ml apro-
tinin, 50 μg/ml leupetin, 1 mM benzamdine, 1 mg/ml
pepstatin]. Forty micrograms of proteins determined by
the BSA method were electrophoretically separated on 8–
15 % sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and transferred to polyvinylidene
fluoride (PVDF) membrane. The membranes were
blocked with 5 % skim milk in TBS-T buffer [20 mM Tris
(pH 7.4), 150 mM NaCl, 0.1 % Tween 20] at room
temperature for 1 h. The membranes were incubated with
primary and secondary antibodies and then washed 3
times with TBS-T buffer for 10 min. Finally, the proteins
were detected with an ECL western blotting detection re-
agent. The densities of each band were determined with a
fluorescence scanner (LAS 3000, Fuji Film, Tokyo, Japan)
and analyzed with Multi Gauge V3.0 software.
Statistical analysis
Experiments were repeated at least 3 times with consist-
ent results. Unless otherwise stated, data are expressed
as the mean ± SD. ANOVA was used to compare the ex-
perimental groups to the control values, whereas com-
parisons between multiple groups were performed using
a Tukey’s multiple comparison test. The results were sta-
tistically significant at P <0.05.
Results
Silibinin stimulated ROS production from mitochondria
We examined the intracellular ROS involved in the initi-
ation of apoptotic signaling, which are the byproducts of
normal cellular oxidative processes [27]. As a result,
intracellular ROS levels were significantly increased in a
time-dependent manner in PC-3 cells treated with silibi-
nin (Fig. 1a). Although silibinin stimulated robust ROS
production up to 24 h, we confirmed viable cells by
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MTT assay (Additional file 1: Figure S1A). To identify
the cellular source of ROS production by silibinin, PC-3
cells were treated with silibinin in the presence or ab-
sence of various ROS inhibitors (general ROS scavenger,
NAC and Tempol; NOX inhibitor, DPI; H2O2 scavenger,
CAT). The results showed that DPI selectively suppressed
silibinin-stimulated ROS production, whereas NAC, Tem-
pol and CAT had weak effects (Fig. 1b). These ROS were
attenuated in early time stage for 3 h (Additional file 1:
Figure S1B), suggesting that persistent and excessive ROS
were associated with DPI-specific mechanism. DPI is
known to be an inhibitor of mitochondrial ROS and NOX
system. Therefore, to visualize ROS generated from mito-
chondria, PC-3 cells after silibinin treatment were stained
with MitoSOX, a selective dye of mitochondrial-derived
ROS. As a result, confocal microscopy image showed that
silibinin enhanced the fluorescence intensity of MitoSOX
in the mitochondrial portion and pretreatment with DPI
inhibited mitochondrial ROS generation (Fig. 1c). These
results suggested that silibinin stimulated ROS production
from mitochondria.
Silibinin triggered mitochondrial ROS derived from NOX4
expression
It has been suggested that NOX family members are a
major source of mitochondrial ROS. A DPI has been used
to inhibit ROS production mediated by NOX [28]. Thus,
we confirmed the mRNA expression of various NOX iso-
forms after treatment of silibinin (Fig. 2a). Interestingly,
among NOX isoforms, NOX4 was significantly increased
by treatment of silibinin in a time-dependent manner but
others expression was not changed. As expected, the in-
creased expression of NOX4 by silibinin was suppressed
by pretreatment with DPI (Fig. 2b). NOX4 is known to be
localized at the mitochondrial membrane, from which
stimulate ROS production [29]. Therefore, to confirm that
production of mitochondrial ROS is associated with
NOX4, confocal microscopy was used to visualize the in-
tensity of fluorescence by using FITC-conjugated anti-
rabbit IgG and MitoSOX. The result showed that NOX4
was colocalized with silibinin-stimulated mitochondrial
ROS (Fig. 2c). Taken together, it was demonstrated that
potential cellular source of mitochondrial ROS production
Fig. 1 Silibinin stimulated the generation of ROS derived from mitochondria in PC-3 cells. a PC-3 cells were treated with 150 μM silibinin up to
24 h and ROS production was determined by the fluorescence of DCFH-DA with flow cytometry. b PC-3 cells were treated with 150 μM silibinin
for 12 h with the presence or absence of 0.5 μM DPI, 5 mM NAC, 10 μM Tempol and 100 U/ml CAT. c Representative images showed mitochondrial
ROS production by confocal microscopy with MitoSOX, a mitochondrial ROS dye. Data are presented as *p <0.001 vs. the control group
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was NOX4 system and that these ROS production may be
involved in cellular apoptosis pathway.
Silibinin induced apoptosis through mitochondrial ROS
Previous studies reported that generation of intracellular
ROS induce apoptosis in various cancer cells [30]. First,
we confirmed evidence of apoptotic events including
change of MMP and expression of apoptosis-related pro-
teins. MMP is associated with mitochondrial function,
followed by the release of cytochrome c and activation
of caspase-9 and −3, which are important steps of the
intracellular signaling cascade in apoptosis [31]. The ef-
fect of silibinin on MMP was analyzed using DiOC6, a
fluorescent dye, in PC-3 cells. Changes of MMP signifi-
cantly occurred after treatment with 150 μM of silibinin
for up to 48 h (Fig. 3a). In addition, silibinin reduced pro-
caspase-3 and increased cleavage form of PARP in a time-
dependent manner (Fig. 3b), as we previously reported
[32]. Next, to identify whether production of mitochon-
drial ROS by silibinin is associated with apoptosis, we con-
firmed the change of silibinin-induced apoptosis with the
presence or absence of DPI. The results showed that DPI
inhibited silibinin-induced apoptosis and expression of
apoptosis-related proteins including caspase-3 and PARP
(Fig. 3c and d). Taken together, silibinin induced apoptosis
through regulation of MMP and the apoptosis is pro-
moted from generation of mitochondrial ROS by NOX4.
Silibinin induced ER stress through disruption of
intracellular Ca2+ homeostasis
It was well established that apoptosis is regulated by ER
stress response from unfolded protein accumulation
[33]. To examine whether silibinin causes ER stress in
PC-3 cells, we investigated Ca2+ homeostasis and the ex-
pression of ER stress-related proteins. The expression of
Bip, IRE1α, p-eIF2α, ATF4 and CHOP, a transcription
factor as pro-apoptotic factor, was time-dependently in-
creased after silibinin treatment (Fig. 4a). The splicing
form of X-box binding proteins-1 (XBP-1) mRNA level,
which is a major pathway of ER stress signaling, and
mRNA levels of Bip and CHOP were increased in a
time-dependent manner (Fig. 4b). Because ER is main
storage of the intracellular Ca2+, we observed whether
UPR by silibinin is associated with change of Ca2+ flux.
As a result, fluorescence intensity of Fluo-3/AM-incu-
bated cells was continuously increased during the 24 h
of silibinin treatment, indicating that silibinin elevated
the level of intracellular Ca2+ in a time-dependent man-
ner. These occurrences were significantly suppressed by
pretreatment with BAPTA/AM, an intracellular Ca2+
Fig. 2 Silibinin triggered mitochondrial ROS derived from NOX4 in PC-3 cells. a NOX isoforms were detected by PCR using specific primers for
NOX isoforms. GAPDH was used as a loading control. b NOX4 expression was analyzed after treatment with 150 μM silibinin for 24 h with the
presence or absence of 0.5 μM DPI. c Representative images obtained by confocal fluorescence microscopy with MitoSOX after exposure to silibinin
for 24 h. After fixation and permeabilization, it was cell stained with our Nox4 antibody and appropriate FITC-conjugated secondary antibody. Nuclei
were counter-stained with DAPI
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chelator (Fig. 4c). In addition, to confirm the role of Ca2+
signaling in ER stress response, cells were pretreated with
Ca2+ chelator BAPTA/AM. As a result, ER stress-related
proteins were significantly reduced by BAPTA/AM
(Fig. 4d). Finally, pretreatment with BAPTA/AM re-
duced silibinin-induced apoptosis (Fig. 4e) and inhibited
the expression of apoptosis-related proteins, such as
pro-caspase-3 and PARP (Fig. 4f ). These results indi-
cated that Ca2+ signaling played an important role in
silibinin-mediated ER stress response and apoptosis in
PC-3 cells.
Silibinin induced ROS-mediated Ca2+ signaling and ER
stress response
Previous studies suggested that ROS are an important
component leading to UPR in the ER and ER stress-
triggered apoptosis [34, 35]. To examine whether ROS are
correlated with the silibinin-induced ER stress, intracellu-
lar Ca2+ flux and ER stress-related proteins were observed
after pretreatment with DPI. The pretreatment with DPI
reduced the intracellular Ca2+ levels and the expression of
Bip and CHOP in silibinin-treated PC-3 cells (Fig. 5a and
b). These results indicated that downstream targets of
mitochondrial ROS are both Ca2+ signaling and ER stress
response, probably caused by mitochondrial dysfunction.
These data strongly suggested that mitochondrial ROS
production by silibinin was essential for induction of ER
stress via Ca2+ signaling pathway and ultimately led to
apoptosis in PC-3 cells.
Discussion
Currently, more effective strategies must be necessary to
develop novel therapeutic targets and molecular regula-
tory agents for cancer diseases. Recently, the role of
phytochemicals has been suggested in various cancer
managements, especially polyphenolic compounds [36].
Silibinin isolated from milk thistle is a polyphenolic fla-
vonoid and it has been studied for applications as antican-
cer agents [37]. In addition, some report proposed that
silibinin suppresses the tumor growth and exhibits anti-
proliferative, pro-apoptotic and anti-angiogenic effects of
dietary feeding of silibinin on PC-3 xenograft in vivo [38].
However, complete mechanism on anticancer effect of sili-
binin has not been clearly identified until now. To further
elucidate the silibinin-induced intracellular mechanism,
we investigated the various phenomena involved in cell
death such as ROS and ER stress response.
First, to investigate silibinin induce cancer selectively
death mechanism, apoptosis and ROS were measured in
prostate cell lines including androgen-independent PC-
3, androgen-dependent LNCaP and normal prostate epi-
thelial RWPE-1 cells. The results indicated that silibinin
possesses selective effects on apoptotic cell death and
ROS in PC-3 and LNCaP cells, while not affecting the
Fig. 3 Silibinin induced apoptosis through mitochondrial ROS in PC-3 cells. a PC-3 cells were treated with 150 μM silibinin for indicated times.
MMP was determined using fluorescence dye DiOC6 by flow cytometry. b Protein expression was analyzed by western blotting with antibodies
for pro-caspase-3 and PARP. β-Actin was used as a loading control. c Apoptosis was analyzed after treatment with 150 μM silibinin for 48 h with
the presence or absence of 0.5 μM DPI by flow cytometry. d Protein expression was analyzed by western blotting. β-Actin was used as a loading
control. Data are presented as mean ± SD (n = 3 in each group). *p <0.001 vs. the control group
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RWPE-1 cells (Additional file 1: Figure S2A and B). ROS
are major molecules of intracellular signaling cascades
and trigger mitochondria-associated events including
apoptosis [39], which is generated from various cellular
sources such as NOXs, mitochondrial respiration and
extracellular stress. Our results showed that silibinin sig-
nificantly stimulated the intracellular ROS production in
a time-dependent manner. Among various cellular
sources of ROS production, NOX4 produces ROS of
superoxide type in the mitochondria. In our system,
whereas early ROS production by silibinin was inhibited
by all ROS inhibitors, persistent and excessive ROS pro-
duction were attenuated by only DPI treatment, suggest-
ing that silibinin mainly stimulated NOX4-dependent
Fig. 4 Silibinin induced ER stress response through disruption of Ca2+ homeostasis. a Expression of ER stress-related proteins was detected by
western blotting with antibodies for Bip, IRE1α, p-eIF2α, eIF2α, ATF4, CHOP and β-Actin was used as a loading control. b ER stress-related mRNAs were
detected by RT-PCR with primers for XBP1, Bip, CHOP and GAPDH was used as a loading control. c PC-3 cells were treated with 150 μM silibinin for
24 h with the presence or absence of 2 μM BAPTA/AM. The intracellular Ca2+ concentration was determined by the fluorescence of fluo-3/AM with flow
cytometry. d Protein expression was analyzed by western blotting. β-Actin was used as a loading control. e Apoptosis was analyzed after treatment of
150 μM silibinin for 48 h with the presence or absence of 2 μM BAPTA/AM by flow cytometry. f The effects of BAPTA/AM on silibinin-induced apoptosis were
measured by western blotting. β-Actin was used as a loading control. Data are presented as mean ± SD (n= 3 in each group). *p <0.001 vs. the control group
Fig. 5 Mitochondrial ROS mediated silibinin-induced ER stress in PC-3 cells. a PC-3 cells were treated with 150 μM silibinin for 24 h with the presence or
absence of 0.5 μM DPI. The intracellular Ca2+ concentration was determined by the fluorescence of fluo-3/AM. b The effects of DPI on silibinin-induced ER
stress were measured by western blotting. β-Actin was used as a loading control. Data are presented as mean ± SD (n= 3 in each group). *p <0.001 vs. the
control group.
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ROS of superoxide type. Also, we observed the mito-
chondrial ROS production and mRNA expression of the
variety of NOX isoforms in silibinin-treated PC-3 cells.
NOX plays an important role in regulation of mitochon-
drial ROS. Also it was reported that NOX4 is localized
at various subcellular compartments such as mitochon-
dria, ER, plasma membrane and nucleus [40–42]. Our
results showed that silibinin-stimulated ROS were colo-
calized with NOX4 in mitochondrial portion confirmed
by MitoSOX. Expression of NOX4 increased by silibinin
was suppressed by DPI, a specific NOX inhibitor.
Although some studies have reported that DPI inhibits
NOX activity, like our results, another reported that DPI
inhibited NOX4 expression in PMA-stimulated U87MG
cells [43]. In addition, DPI inhibited silibinin-induced
apoptosis and the expression of apoptosis proteins. These
results suggested that NOX4 are the primary source of
silibinin-stimulated mitochondrial ROS production and
these ROS are involved in apoptosis process by modulat-
ing NOX4-driven ROS generation from mitochondria.
Some studies reported that intracellular Ca2+ flux also
mediates multiple cellular signaling cascades of survival
and apoptosis. Release of Ca2+ from ER and high Ca2+
concentration in cytosol trigger cell death in human
cancer cell lines [44]. Our results indicated that silibinin
markedly increased the level of intracellular Ca2+ up to
24 h after treatment. And these effects were prevented
by pretreatment with Ca2+ chelator BAPTA/AM. Also
BAPTA/AM inhibited silibinin-induced apoptosis and
the expression of apoptosis proteins. From these results,
silibinin provoked the disruption of Ca2+ homeostasis,
leading to cellular apoptosis. Also Ca2+ signaling is con-
sidered as one of the second messengers strongly in-
volved in ER stress response [45]. ER stress occurs due
to the accumulation of unfolded proteins and disruption
of Ca2+ homeostasis, and triggers specific signaling path-
way with UPR through three key proteins, including
IRE1α, ATF4 and PERK. Silibinin induced the expression
of ER stress proteins and spliced XBP1 mRNA. In
addition, pretreatment with BAPTA/AM markedly de-
creased the expression of Bip and CHOP. So far, 14 cas-
pase family members have been identified [46] and play
important roles in ER stress and apoptosis. Silibinin-
induced apoptosis was reduced by Z-YVAD-FMK, an
inhibitor of caspase-4, which is localized in the ER mem-
brane (Additional file 1: Figure S3). These results indi-
cated that ER stress plays major role in silibinin-induced
apoptosis through Ca2+ signaling. On the observation to
further clarify the role of ROS in Ca2+ flux and ER
stress, blocking of ROS production with DPI caused the
reduction of Ca2+ level and inhibition of ER stress pro-
teins. It was suggested that ROS generation by silibinin
plays a key role in induction of ER stress triggered from
disruption of Ca2+ homeostasis in PC-3 cells.
Conclusions
In conclusion, our studies demonstrated that silibinin in-
duced apoptosis mediated by activation of ER stress that
requires the disruption of Ca2+ homeostasis through
ROS generation and those ROS were produced, in part,
from mitochondrial NOX system, upstream pathway of
Ca2+ signaling. Therefore, based on these results, regula-
tion of NOX4-driven mitochondrial ROS production
could be a potential target for development of the cancer
therapy and management.
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reticulum; Fluo-3/AM, 4-(6-Acetoxymethoxy-2,7-dichloro-3-oxo-9-xanthenyl)-4′-
methyl-2,2′(ethylenedioxy)dianiline-N,N,N′,N′-tetraacetic acid tetrakis (acetoxymethyl)
ester; IRE1, inositol requiring enzyme 1; MMP, mitochondrial membrane potential;
MTT, 3-(4,5-Dimethyl-thiazol-2-yl)-2,5-diphenyltertrazolium bromide; NOX, NADPH
oxidase; PERK, pancreatic ER kinase (PKR)-like ER kinase; PI, propidium iodide; ROS,
reactive oxygen species; UPR, Unfolded protein response; XBP1, X box-bonding
protein 1
Additional file
Additional file 1: Figure S1. Silibinin reduced cell viability and
stimulated ROS production in human prostate cancer PC-3 cells. (A)
PC-3 cells were incubated with silibinin for indicated concentrations and
times. Cell viability was determined by MTT assay as described in
Materials and Methods. (B) PC-3 cells were treated with 150 μM silibinin
for 3 h with the presence or absence of 0.5 μM DPI, 5 mM NAC, 10 μM
Tempol and 100 U/ml CAT and ROS production was determined by the
fluorescence of DCFH-DA with flow cytometry. Data are presented as mean
± SD (n = 3 in each group). #p <0.05, ¶p <0.01, *p <0.001 vs. the control
group. Figure S2. Silibinin induced apoptosis and ROS production
selectively in prostate cancer cells but not in normal cells (A) Apoptosis of
prostate cell lines was analyzed after treatment with indicated silibinin
concentration for 48 h by flow cytometry. (B) Prostate cell lines were
treated with indicated silibinin concentration for 48 h. ROS production was
determined by the fluorescence of DCFH-DA with flow cytometry. Data are
presented as mean ± SD (n= 3 in each group). #p <0.05, ¶p <0.01, *p <0.001
vs. the control group. Figure S3. Silibinin induced ER-dependent apoptosis in
PC-3 cells. Inhibition of apoptosis by Z-YVAD-FMK, a caspase-4 inhibitor, was
analyzed after treatment with 150 μM silibinin for 48 h with the presence or
absence of 5 μM Z-YVAD-FMK by flow cytometry. Data are presented as mean
± SD (n= 3 in each group). *p <0.001 vs. the control group. (PPTX 720 mb)
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